12:15 PM EDT, 07/24/2024 (MT Newswires) -- Charles River Laboratories International ( CRL ) has made an investment in Autobahn Labs, joining a fundraising round led by Autobahn's founding investor, Samsara BioCapital, the companies said Wednesday.

They said Charles River will be the preferred research partner for Autobahn's pipeline of early-stage, preclinical therapeutics' programs as part of their partnership. The agreement will also grant Autobahn preferred access to Charles River's drug discovery and development capabilities.

The investment and collaboration will enable Autobahn to expand its partnerships with academic institutions, advance preclinical programs, and identify new opportunities for therapeutics development, the companies said. Justin Bryans, chief scientific officer, discovery for Charles River, has joined Autobahn's board.

Charles River shares were up about 2% in recent trading.

Price: 224.95, Change: +4.67, Percent Change: +2.12